Epirus Biopharmaceuticals epirusbiopharma.com


Epirus is building a global biosimilar enterprise to improve patient access to important medicines. The Company's strategy for commercial success relies on targeted approaches for diverse global markets. For emerging markets with accessible regulatory frameworks for biosimilars, Epirus develops partnerships with local companies to accelerate regulatory approval and commercialize its products. For high-growth global markets where local manufacturing confers strategic and operational advantages, ...Show all

Epirus is building a global biosimilar enterprise to improve patient access to important medicines. The Company's strategy for commercial success relies on targeted approaches for diverse global markets. For emerging markets with accessible regulato...Show all

Company (Merged)

Phone:

Fax:

699 Boylston Street
11th Floor
Boston, 02116
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Epirus Biopharmaceuticals $78M Jul 15, 2014

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Epirus Biopharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 9 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Heterocyclic inhibitors of the sodium channel Feb 26, 2015 Application